What's in Guangdong Hengrui Pharmaceutical Co., Ltd's pipeline?

Guangdong Hengrui Pharmaceutical Co., Ltd has 18 drugs in our index: 1 marketed, 0 filed, 3 in Phase 3, 7 in Phase 2, 7 in Phase 1.

Which companies overlap with Guangdong Hengrui Pharmaceutical Co., Ltd's portfolio?

Top competitors by shared drug class: Pfizer, Jiangsu HengRui Medicine Co., Ltd., GlaxoSmithKline, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Bristol-Myers Squibb.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/guangdong-hengrui-pharmaceutical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Guangdong Hengrui Pharmaceutical Co., Ltd — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Guangdong Hengrui Pharmaceutical Co., Ltd pipeline: 1 marketed, 0 filed, 3 Phase 3, 7 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 3 Phase 3 7 Phase 2 7 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Moxifloxacin Hydrochloride Tablets	Moxifloxacin Hydrochloride Tablets	marketed
SHR-1905 Injection	SHR-1905 Injection	phase 3	PD-1 inhibitor	PD-1	Oncology
SHR-1819	SHR-1819	phase 3	Small molecule	Unknown	Unknown
HR-1703	HR-1703	phase 3	Tyrosine kinase inhibitor		Oncology

Therapeutic area mix

Oncology · 2
Respiratory · 1
Unknown · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Pfizer · 3 shared drug classes
Jiangsu HengRui Medicine Co., Ltd. · 3 shared drug classes
GlaxoSmithKline · 2 shared drug classes
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · 2 shared drug classes
Bristol-Myers Squibb · 2 shared drug classes
First Affiliated Hospital of Zhejiang University · 2 shared drug classes
Akeso · 2 shared drug classes
Sun Yat-sen University · 2 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for Guangdong Hengrui Pharmaceutical Co., Ltd:

Cite this brief

Drug Landscape (2026). Guangdong Hengrui Pharmaceutical Co., Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/guangdong-hengrui-pharmaceutical-co-ltd. Accessed 2026-05-17.